Series B funding round for Odyssey Therapeutics raising $170M in October 2022
Series B funding round for Odyssey Therapeutics raising $170M in October 2022
| Investor | Firm Type | Partner |
|---|
General CatalystLEAD | Venture Capital | — |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Private | — | |
| Investment Bank | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Hedge Fund | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — |
This company has completed 4 funding rounds. Current round is highlighted.
Total Raised
$700M
Top Valuation
-
Odyssey Therapeutics raised $170M in a Series B round.
The round was announced on 10/01/22.
The round was led by General Catalyst.